HOME >> BIOLOGY >> NEWS
'Gold Bug' sheds light on how some gold deposits formed

AMHERST, Mass. - For centuries, scientists have wondered why gold is found in two forms - as a solid in deposits close to the Earth's crust, and in solution, often far removed from gold-ore deposits. A fairly simple lab experiment conducted at the University of Massachusetts may lead to an understanding of how the precious metal came to be available in disparate forms, and how some gold-ore deposits might have been formed.

In research related to pollution clean-up, a team of UMass microbiologists led by noted researcher Derek Lovley has extracted gold solids from water containing dissolved gold. The work uses technology Lovley developed 10 years ago to clean up heavily polluted water and soil around the U.S. using bacteria and archaea, or ancient micro-organisms, to break down heavy metals in affected environments.

Like uranium, cadmium, and other heavy metals, gold is precious and useful to humans. Lovley notes that dissolved gold, however, is useless because it can't be manipulated and formed into objects of value or beauty. He says when either solid or liquid gold is ingested, it is toxic to most life forms. On the other hand, liquid gold and many other heavy metals are not toxic to a group of microbes called extremophiles, or simple life forms known to thrive in environments where others cannot live.

With this in mind, the UMass researchers asked if extremophiles might have ingested the liquid gold found in hydrothermal vents, hot springs, and other hot places, and left it scattered as deposits of solid gold in places that now are below the surface of the Earth. This would explain how the metal came to be in two different forms in very different environments. If that is the case, the team wondered if microbes could duplicate the process in the laboratory and extract valuable solids from liquid containing dissolved gold.

"A vast number of bacteria and archaea have the ability to transfer electrons to iron throug
'"/>

Contact: Paula Hartman Cohen
phcohen@admin.umass.edu
413-545-2987
University of Massachusetts at Amherst
7-Aug-2001


Page: 1 2 3

Related biology news :

1. New fossil sheds light on old mystery
2. Fossil genes reveal how life sheds form and function
3. OHSU-VAMC study sheds light on estrogens benefit for MS
4. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
5. Study sheds new light on genetic risk for Parkinsons disease
6. Equine clonings triple play sheds light on calcium, cell signaling, human disease
7. UCLA study sheds new light on island evolution
8. Research sheds new light on evolution
9. Better model of cancer development sheds light on potential angiogenesis target
10. Media advisory - wildland fire impacts on watersheds
11. Enzyme discovery sheds light on causes of rare disease, cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gold Bug sheds light how some gold deposits formed

(Date:10/30/2014)... therapeutics present unique challenges when it comes to ... harm. New consensus guidelines for toxicity testing that ... characteristics of these novel biopharmaceuticals are presented in ... from Mary Ann Liebert, Inc. publishers . ... Nucleic Acid Therapeutics website until November 30, ...
(Date:10/30/2014)... Oct. 29, 2014  Securus Technologies, a ... technology solutions for public safety, investigation, corrections ... deployed exciting enhancements to its THREADS™ product, ... provide actionable intelligence and focused leads for ... drive technological innovation through identifying and delivering ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2
(Date:10/30/2014)... , Oct. 30, 2014  Regado Biosciences, Inc. ... will hold a conference call and live audio webcast ... to discuss its third quarter 2014 financial results. ... call by dialing (888) 347-1165 for domestic callers or ... be webcast live under the investor relations section of ...
(Date:10/30/2014)... (Oct. 29, 2014) – The severe flooding that devastated ... been less destructive if the bridges, roads and other ... new study from the University of Colorado Denver. , ... infrastructure," said Jimmy Kim, PhD, associate professor of structural ... Applied Science and lead author the study. "There is ...
(Date:10/27/2014)... October 27, 2014 The new ... Type (High & Medium), Sub-type (Primary & Secondary), ... Infrastructure & Transportation & Power Generation) - Trends ... GIS market with analysis and forecasting of the ... Data Tables with 52 Figures spread through 146 ...
(Date:10/27/2014)... TORONTO , Oct. 27, 2014 ... (OTCQB: GNBT) today announced two presentations demonstrating that ... its novel proprietary cancer immunotherapeutic AE37 vaccine correlated ... patients. The AE37 cancer vaccine is being developed ... ( www.antigenexpress.com ). The presentations are being made ...
Breaking Biology Technology:Regado Biosciences to Provide Third Quarter 2014 Financial Results 2CU Denver study says upgrading infrastructure could reduce flood damage 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4
Cached News: